Details for New Drug Application (NDA): 213651
✉ Email this page to a colleague
The generic ingredient in METFORMIN HYDROCHLORIDE is metformin hydrochloride. There are forty-nine drug master file entries for this compound. Eighty-four suppliers are listed for this compound. Additional details are available on the metformin hydrochloride profile page.
Summary for 213651
Tradename: | METFORMIN HYDROCHLORIDE |
Applicant: | Ajanta Pharma Ltd |
Ingredient: | metformin hydrochloride |
Patents: | 0 |
Suppliers and Packaging for NDA: 213651
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
METFORMIN HYDROCHLORIDE | metformin hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 213651 | ANDA | Ajanta Pharma USA Inc. | 27241-188 | 27241-188-60 | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (27241-188-60) |
METFORMIN HYDROCHLORIDE | metformin hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 213651 | ANDA | Ajanta Pharma USA Inc. | 27241-189 | 27241-189-60 | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (27241-189-60) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 500MG | ||||
Approval Date: | Apr 9, 2020 | TE: | AB2 | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 1GM | ||||
Approval Date: | Apr 9, 2020 | TE: | AB2 | RLD: | No |
Complete Access Available with Subscription